phase readout
saveNCT07406334: A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose
RECRUITINGupdated 25m ago
community read0 votes
Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pneumonia, Bacterial
view source ↗
comments(0)
5-min edit window · permanent after that